Kyungbo Kim

1.4k citations
46 papers · 1.1k indexed · h-index 17
Topics
Ubiquitin and proteasome pathways (20 papers)Peptidase Inhibition and Analysis (18 papers)Protein Degradation and Inhibitors (11 papers)

In The Last Decade

Kyungbo Kim

46 papers receiving 1.1k citations

Peers

Kyungbo Kim
Comparison fields: 5 of 83
  • Molecular Biology 922
  • Oncology 472
  • Hematology 185
  • Organic Chemistry 83
  • Pharmacology 66
Replace Wen‐Hsing Lin with:
Wen‐Hsing Lin Taiwan
Zuping Xia United States
Linda Rickardson Sweden
Frida Ponthan United Kingdom
Xavier Billot Canada
Natalie O. Karpinich United States
Takumi Kawabe United States
Sumeer Dhar Sweden
Matthew Labenski United States
Smita Matkar United States
Kyungbo Kim relative to Wen‐Hsing Lin Taiwan Wen‐Hsing Lin's profile →
Citations per field
00.5×1.5×1.8×
Wen‐Hsing Lin · 1×
Citations per year

Countries citing papers authored by Kyungbo Kim

Since Specialization
Citations

This map shows the geographic impact of Kyungbo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyungbo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyungbo Kim more than expected).

Fields of papers citing papers by Kyungbo Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyungbo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyungbo Kim. The network helps show where Kyungbo Kim may publish in the future.

Co-authorship network of co-authors of Kyungbo Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Kyungbo Kim. A scholar is included among the top collaborators of Kyungbo Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyungbo Kim. Kyungbo Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 15
3 6
4 7
5 13
6 13
7 13
8 17
9 6
10 12
11 26
12 11
13 30
14 20
15 161
16 49
17
A Study on the Wind Data Analysis and Wind Speed Forecasting in Jeju Area
3
18 98
19 12
20 56

About Kyungbo Kim

Kyungbo Kim is a scholar working on Oncology, Molecular Biology and Pharmacology, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (20 papers), Peptidase Inhibition and Analysis (18 papers) and Protein Degradation and Inhibitors (11 papers). The work is most often cited by research in Oncology (472 citations), Hematology (185 citations) and Molecular Biology (922 citations). Kyungbo Kim has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Marie Wehenkel, Hyosung Lee, Hollie I. Swanson, Kedra Cyrus, Eun‐Young Choi, Paola Bargagna‐Mohan, Royce Mohan, Chang‐Guo Zhan, Eunyoung Choi and Hyeong‐jun Han. Their work appears in journals such as PLoS ONE, The Journal of Physical Chemistry B and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026